65 FR 48 pgs. 13013-13014 - Prospective Grant of Exclusive License: Use of Thymosin ß4 for Wound Healing Applications; Correction
Type: NOTICEVolume: 65Number: 48Pages: 13013 - 13014
FR document: [FR Doc. 00-5785 Filed 3-9-00; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive License: Use of Thymosin ß4 for Wound Healing Applications; Correction
The notice published in the February 28, 2000 Federal Register -announcing the prospective grant of an exclusive license for use of thymosin ß4 for wound healing applications (65 FR 10505)-incorrectly listed one of the serial numbers for the subject invention as "60/094,960" under the SUMMARY section. NIH is publishing this notice to correct this serial number to read "60/094,690." In view of this correction, to allow interested parties adequate time to respond, the DATES section is also amended to read "Only written comments and/or license applications which are received by the National Institutes of Health on or before June 8, 2000 will be considered."
Dated: March 6, 2000.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of Technology Transfer.
[FR Doc. 00-5785 Filed 3-9-00; 8:45 am]
BILLING CODE 4140-01-M